Juraszek A. L., Atz A. M., Shirali G. S.. Echocardiographic diagnosis of partial obstruction of Blalock-Taussig shunts. Cardiology in the Young 2002; 12 (2):189-191.
Juraszek A. L., Edwards A. V., Phelps A., Burch J. B., Wessels A.. Spatio-temporal description of the development of the mouse cardiac conduction system using a cGATA-6 gene enhancer marker (meeting abstract). Journal of the American College of Cardiology 2002; 39 (5):A408.
Jutte S.. Drug therapy QandA. Mexiletine for neuropathic pain. Patient Care for the Nurse Practitioner 2002; ():2p.
Jutte S. B., Blair M. M., Ragucci K. R.. Health care provider survey of clinical pharmacy services in a family medicine clinic (meeting abstract). Pharmacotherapy 2002; 22 (10):379.
Kalas J. S., Spencer A. P., Chung J., Kenyon K. W., Kluger J., White C. M.. Does magnesium prophylaxis alter ibutilides therapeutic efficacy in atrial fibrillation patients (meeting abstract). Circulation 2002; 106 (19):3130.
Kalus J. S., Nappi J. M.. Role of race in the pharmacotherapy of heart failure. Annals of Pharmacotherapy 2002; 36 (3):471-478.
Kaplan A. P.. Chronic urticaria and angioedema. New England Journal of Medicine 2002; 346 (3):175-179.
Kaplan A. P.. Chronic urticaria and angioedema - Reply. New England Journal of Medicine 2002; 347 (3):222.
Kaplan A. P.. Chronic urticaria and angioedema - Reply. New England Journal of Medicine 2002; 347 (21):1724.
Kaplan A. P., Joseph K., Silverberg M.. Pathways for bradykinin formation and inflammatory disease. Journal of Allergy & Clinical Immunology 2002; 109 (2):195-209.
Karim M. A., Suzuki K., Fukai K., Oh J., Nagle D. L., Moore K. J., Barbosa E., Falik-Borenstein T., Filipovich A., Ishida Y., Kivrikko S., Klein C., Kreuz F., Levin A., Miyajima H., Regueiro J., Russo C., Uyama E., Vierimaa O., Spritz R. A.. Apparent genotype-phenotype correlation in childhood, adolescent, and adult Chediak-Higashi syndrome. American Journal of Medical Genetics 2002; 108 (1):16-22.
Kasman L. M., Kasman A., Westwater C., Dolan J., Schmidt M. G., Norris J. S.. Overcoming the phage replication threshold: a mathematical model with implications for phage therapy. Journal of Virology 2002; 76 (11):5557-5564.
Kasman L. M., Westwater C., Schmidt M. G., Dolan J., Norris J. S., Kasman A.. Evidence for a phage proliferation threshold? Authors' reply. Journal of Virology 2002; 76 (24):13123-13124.
Kaste L. M., Nesmith S. A., Michel Y.. High school absence and caries experience (meeting abstract). Journal of Dental Research 2002; 81 (NSI):3525.
Katikaneni L. D., Salle F. R., Hulsey T. C.. Neonatal hair analysis for benzoylecgonine: A sensitive and semiquantitative biological marker for chronic gestational cocaine exposure. Biology of the Neonate 2002; 81 (1):29-37.
Katikaneni L.D., Marcias M., Ebling M., Wagner C.L., Hulsey T.C.. Trends in neonatal course and neurodisability of neonatal intensive care graduates (NICUG) during 2 periods - 1992 to 1995 (A) and 1996 to 1999 (B) (meeting abstract). Pediatric Research 2002; 51 (4):2382.
Katz P. O., Castell D. O., Chen Y. S., Sostek M. B.. Esomeprazole 40 mg twice daily maintains pH>4 for more than 80% of a 24 hour time period (meeting abstract). American Journal of Gastroenterology 2002; 97 (9):61.
Kaul P., Singh I., Turner R. B.. Effect of rhinovirus challenge on antioxidant enzymes in respiratory epithelial cells. Free Radical Research 2002; 36 (10):1085-1089.
Keane T. E.. Prostate-specific antigen as a marker of disease activity in prostate cancer - The Partin et al article reviewed. Oncology (Huntington) 2002; 16 (8):1048-+.
Kelley R. E., Weart C. W.. Preventing stroke with evidence-based care. Patient Care 2002; 36 (8):48+.
Kelly M. M., Hoel B. D., Voelkel-Johnson C.. Doxorubicin pretreatment sensitizes prostate cancer cell lines to trail induced apoptosis which correlates with the loss of C-FLIP expression. Cancer Biology and Therapy 2002; 1 (5):520-527.
Kelly Z. D., Barth J. L., Fox E. J., Greene L. M., Knaak C., Murphy A. A., Argraves W. S., Gallagher W. M.. Gene expression profile analysis of tumor-derived cell lines overexpressing the candidate tumor suppressor gene, fibulin-1 (meeting abstract). British Journal of Cancer 2002; 86 (S1):32S.
Kennedy K. J., Orwig K. S., Dix T. A., Christopher J., Jaffa A. A.. Synthesis and analysis of potent, more lipophilic derivatives of the bradykinin B-2 receptor antagonist peptide Hoe 140. Journal of Peptide Research 2002; 59 (4):139-148.
Key J. D., Washington E. C., Hulsey T. C.. Reduced emergency department utilization associated with school-based clinic enrollment. Journal of Adolescent Health 2002; 30 (4):273-278.
Key Janice D., Marsh Linda D.. Missed opportunities for prevention: Failure to identify smoking in the parents of adolescent patients. Substance Abuse 2002; 23 (4):215-221.
Khaldi A., Chiueh C. C., Bullock M. R., Woodward J. J.. The significance of nitric oxide production in the brain after injury. Annals of the New York Academy of Sciences 2002; 962 ():53-9.
Khaldi A., Chiueh C. C., Bullock M. R., Woodward J. J.. The significance of nitric oxide production in the brain after injury. Annals of the New York Academy of Sciences 2002; 962 ():53-59.
Khan M., Giri S., Singh I., Singh A. K.. Inhibition of peroxisomal functions and production of excessive oxidative stress by psychosine in rat C6 glial cells (meeting abstract). Journal of Neurochemistry 2002; 81 (S1):110.
Khan M., Sekhon B. K., Sekhon C. S., Singh I., Singh A. K.. Sphingolipids in rat model of transient focal cerebral ischemia: Implications for stroke injury (meeting abstract). Journal of Neurochemistry 2002; 81 (S1):110.
Kibbey M. M., Jameson M. J., Rosensweig S. A.. The insulin-like growth factor (IgF) system in squamous cell carcinomas of the pharynx and oral cavity (meeting abstract). Journal of Dental Research 2002; 81 (NSI):869.
Kikuchi Y., Kaplan A. P.. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. Journal of Allergy & Clinical Immunology 2002; 109 (1):114-118.
Killeen T. K., Haight B., Brady K., Herman J., Michel Y., Stuart G., Young S.. The effect of auricular acupuncture on psychophysiological measures of cocaine craving. Issues in Mental Health Nursing 2002; 23 (5):445-459.
Kimbrell T. A., Dunn R. T., George M. S., Danielson A. L., Willis M. W., Repella J. D., Benson B. E., Herscovitch P., Post R. M., Wassermann E. M.. Left prefrontal-repetitive transcranial magnetic stimulation (rTMS) and regional cerebral glucose metabolism in normal volunteers. Psychiatry Research: Neuroimaging 2002; 115 (3):101-113.
Kimbrell T. A., Ketter T. A., George M. S., Little J. T., Benson B. E., Willis M. W., Herscovitch P., Post R. M.. Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biological Psychiatry 2002; 51 (3):237-252.
King D. E., Dickerson L. M., Sack J. L.. Acute management of atrial fibrillation: Part II. Prevention of thromboembolic complications. American Family Physician 2002; 66 (2):261-264.
King D. E., Dickerson L. M., Sack J. L.. Acute management of atrial fibrillation: Part I. Rate and rhythm control. American Family Physician 2002; 66 (2):249-256.
King D. E., Mainous A. G., Pearson W. S.. C-reactive protein, diabetes, and attendance at religious services. Diabetes Care 2002; 25 (7):1172-1176.
King D. E., Mainous A. G., Pearson W. S.. C-reactive protein, diabetes, and attendance at religious services. Diabetes Care 2002; 25 (7):1172-1176.
Kirby D. S., Gold M. R., Rashba E. J., Shorofsky S. R.. Postentrainment activation sequence: Diagnostic of the supraventricular tachycardia mechanism?. Journal of Cardiovascular Electrophysiology 2002; 13 (4):410-412.
Klar N., Lipsitz S. R., Parzen M., Leong T.. An exact bootstrap confidence interval for kappa in small samples. Journal of the Royal Statistical Society. Series D 2002; 51 (P4):467-478.
Knapp D. R., Crouch R. K., Ball L. E., Gelasco A. K., Ablonczy Z.. Mass spectrometric analysis of G protein-coupled receptors. Methods in Enzymology 2002; 343 ():157-161.
Knight J. S.. A quick, "no-polish" technique for small composite repairs. Operative Dentistry 2002; 27 (4):418.
Kokko H.. Transition between SSRI therapies. Patient Care 2002; 36 (4):46.
Kokko H.. Drug therapy QandA. Transition between SSRI therapies. Patient Care for the Nurse Practitioner 2002; ():20.
Kokko H., Hall P. D., Afrin L. B.. Fentanyl-associated syndrome of inappropriate antidiuretic hormone secretion. Pharmacotherapy 2002; 22 (9):1188-1192.
Kokko K. P., Dix T. A.. Monitoring neurotensin. Analytical Biochemistry 2002; 308 (1):34-41.
Kono M., Crouch R. K.. Activation of a red cone pigment (meeting abstract). Investigative Ophthalmology and Visual Science 2002; 43 (S2):4546.
Kortte K. B., Horner M. D., Windham W. K.. The Trail Making Test, Part B: Cognitive flexibility or ability to maintain set?. Applied Neuropsychology 2002; 9 (2):106-109.
Kose S., Tunca Z., Cakmur R., Idiman F., Fidaner C.. Event-related potentials (P300) in conversion disorders - correlations with depression and anxiety ratings (meeting abstract). Biological Psychiatry 2002; 51 (8):140.
Kozel F. A., George M. S.. Meta-analysis of left prefrontal repetitive transcranial magnetic stimulation (rTMS) to treat depression. Journal of Psychiatric Practice 2002; 8 (5):270-275.
